Moderna

News

Moderna's Q1 revenues rocket, thanks to ex-US sales

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

News

Pivotal trial of Moderna's H5N1 bird flu jab gets underway

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu have received shots in the UK and US.

News

OpenAI introduces GPT-Rosalind, its drug discovery AI

In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Moderna agrees $950m settlement of mRNA jab litigation

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

Digital

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

Moderna's Q1 revenues rocket, thanks to ex-US sales

Pivotal trial of Moderna's H5N1 bird flu jab gets underway

OpenAI introduces GPT-Rosalind, its drug discovery AI

GSK's RSV shot cleared in US for all adults

Moderna agrees $950m settlement of mRNA jab litigation

Accelerating the content lifecycle: A 7-step guide for AI in...

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Moderna

Editor's Picks